How COVID-19 Vaccines May Affect Periods
When clinical trials began testing the various COVID-19 vaccines, one question participants weren’t asked about was whether they experienced any changes to their menstrual cycles or unexpected bleeding after getting vaccinated.
Soon after the vaccines were rolled out to the public, however, people began talking to their doctors about what they were experiencing. Many had noticed that their periods had become heavier than normal. Initially, some clinicians were dismissive, write the authors of a new survey on the topic published in the journal Science Advances. “In media coverage, medical doctors and public heal...
Source: TIME: Health - July 18, 2022 Category: Consumer Health News Authors: Kyla Mandel Tags: Uncategorized COVID-19 healthscienceclimate Source Type: news
Novel Antifibrotic Improved Fibrosis in Chronic Hepatitis B
(MedPage Today) -- Investigational hydronidone, when added to entecavir (Baraclude), reduced liver fibrosis for chronic hepatitis B patients, a phase II trial in China found.
In an intention-to-treat analysis of 168 such patients, the direct-acting... (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - July 15, 2022 Category: Gastroenterology Source Type: news
Temple med school gets $4M NIH grant to study Asian-American discrimination in hepatitis B, liver disease care
The focus of the grant is to find out why so few Asian-Americans are screened for the hepatitis B virus, when more than half of the people living with chronic hepatitis B in the United States are Asian-American. (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - July 15, 2022 Category: Health Management Authors: John George Source Type: news
Safety, Response to Inactivated COVID-19 Vaccine in Chronic HBV Safety, Response to Inactivated COVID-19 Vaccine in Chronic HBV
Are inactivated COVID-19 vaccines well tolerated in patients with chronic hepatitis B infection, and do they induce an effective antibody response?Liver International (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 12, 2022 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news
HBV Cure Going Back to the Drawing Board, Researchers Say HBV Cure Going Back to the Drawing Board, Researchers Say
Findings presented at ILC 2022 in London revealed a cure for hepatitis B will not be easily achieved with the drugs currently in development.Medscape Medical News (Source: Medscape Infectious Diseases Headlines)
Source: Medscape Infectious Diseases Headlines - July 5, 2022 Category: Infectious Diseases Tags: Internal Medicine News Source Type: news
Jaundice, Malaise in Woman With Heroin Habit, Inactive Hepatitis B
(MedPage Today) -- HDV diagnosis portends imminent cirrhosis despite initial resolution of symptoms (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - July 5, 2022 Category: Gastroenterology Source Type: news
Guidelines For Children and Postnatal Infectious Disease Testing
FRIDAY, July 1, 2022 -- Children aged<12 years who received postnatal infectious disease testing are exempt from repeat HIV, hepatitis B virus (HBV), and hepatitis C virus (HCV) testing prior to transplant surgery, according to research... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 1, 2022 Category: Pharmaceuticals Source Type: news
Updated U.S. Public Health Service Guideline for Testing of Transplant Candidates Aged < 12 Years for Infection with HIV, Hepatitis B Virus, and Hepatitis C Virus - United States, 2022
This report describes updated public health service guidelines for testing transplant candidates under 12 years of age for HIV, Hepatitis B, and Hepatitis C. (Source: CDC Morbidity and Mortality Weekly Report)
Source: CDC Morbidity and Mortality Weekly Report - June 30, 2022 Category: American Health Tags: Hepatitis B Hepatitis C MMWR Morbidity & Mortality Weekly Report Organ Transplants Source Type: news
South Korea Approves First Domestically Developed COVID-19 Vaccine
SEOUL, South Korea — Health officials in South Korea on Wednesday approved the country’s first domestically developed COVID-19 vaccine for people 18 years or older, adding another public health tool in the fight against a prolonged pandemic.
In clinical trials involving some 4,000 participants in South Korea and five other countries, SK Bioscience’s two-dose SKYCovione vaccine appeared to be more effective than the broadly used AstraZeneca shots in building immunity against infections, officials at South Korea’s Food and Drug Safety Ministry said.
It isn’t immediately clear how officials will ...
Source: TIME: Health - June 29, 2022 Category: Consumer Health News Authors: Kim Tong-hyung / AP Tags: Uncategorized COVID-19 overnight wire Source Type: news
Fatty Liver Disease Drives Rise in Liver Cancer Deaths Fatty Liver Disease Drives Rise in Liver Cancer Deaths
The steep increase in liver cancer deaths is due to the rising rate of NAFLD, rather than alcoholic liver disease or hepatitis B or C, and is mostly driven by the obesity and type 2 diabetes epidemics.Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - June 27, 2022 Category: Endocrinology Tags: Gastroenterology News Source Type: news
Universal Hepatitis B Vaccination in Adults Aged 19-59 Years Universal Hepatitis B Vaccination in Adults Aged 19-59 Years
The ACIP has expanded the indicated age range for universal HepB vaccination to now include adults aged 19-59 years.Morbidity & Mortality Weekly Report (Source: Medscape Hiv-Aids Headlines)
Source: Medscape Hiv-Aids Headlines - June 24, 2022 Category: Infectious Diseases Tags: Public Health & Prevention Journal Article Source Type: news
Father-son team snag $60M for East Bay biotech startup after big Amgen buyout last year
The startup has three drugs — targeting cancer, inflammation and hepatitis B — that were split off from its founders' previous companies buyout by Amgen. (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - June 9, 2022 Category: Health Management Authors: Ron Leuty Source Type: news
A Fourth COVID-19 Vaccine, From Novovax, Passed a Key Stage in the Authorization Process
American adults who haven’t yet gotten vaccinated against COVID-19 may soon get another choice, as advisers to the Food and Drug Administration on Tuesday backed a more traditional type of shot.
Next, the FDA must decide whether to authorize the protein vaccine made by latecomer Novavax as the nation’s fourth coronavirus shot for adults. It’s made with more conventional technology than today’s dominant Pfizer and Moderna shots and the lesser-used Johnson & Johnson option.
Novavax shots are already available in Australia, Canada, parts of Europe and multiple other countries, either for initial va...
Source: TIME: Health - June 8, 2022 Category: Consumer Health News Authors: LAURAN NEERGAARD / AP Tags: Uncategorized COVID-19 healthscienceclimate wire Source Type: news
FDA Advisers Back a New COVID-19 Vaccine, Made By Novavax
American adults who haven’t yet gotten vaccinated against COVID-19 may soon get another choice, as advisers to the Food and Drug Administration on Tuesday backed a more traditional type of shot.
Next, the FDA must decide whether to authorize the vaccine made by latecomer Novavax, a protein vaccine that’s made with a more conventional technology than today’s U.S. options.
Novavax shots are already used in Australia, Canada, parts of Europe and dozens of other countries. But U.S. clearance is a key hurdle for the Maryland-based company.
FDA’s vaccine chief Dr. Peter Marks said another choice in the U....
Source: TIME: Health - June 7, 2022 Category: Consumer Health News Authors: Lauran Neergaard / AP Tags: Uncategorized COVID-19 wire Source Type: news
FDA advisers recommend authorizing Novavax coronavirus vaccine
The Novavax vaccine is a protein vaccine, a more traditional technology found in other commonly used immunizations such as hepatitis B and influenza. (Source: Washington Post: To Your Health)
Source: Washington Post: To Your Health - June 7, 2022 Category: Consumer Health News Authors: Carolyn Y. Johnson Source Type: news
